Aveanna Healthcare Holdings, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Jim Cramer recommended buying Energy Transfer LP (NYSE:ET), calling it 'terrific.' Stifel analyst Robert Hodges reinstated ET with a Buy rating and $25 price target. Cramer also discussed other stocks, including SentinelOne, Corning, Gemini Space Station, Aveanna Healthcare, Reformation, and HPE, citing various analyst ratings and price targets.
Inspire Medical Systems (NYSE:INSP), Cybin (NASDAQ:HELP), and Aveanna Healthcare (NASDAQ:AVAH) are flagged as overbought with RSI values above 70. INSP reported strong Q2 results and raised FY26 guidance, while AVAH received an Overweight rating and higher price target from Barclays. All three stocks showed significant gains over the past month.
Insider trading activity for August 25, 2026, included purchases by executives at TTM Technologies (TTMI), Alpha Metallurgical (AMR), Kura Oncology (KURA), TEAM INC (TISI), and Dorchester Minerals (DMLP). Notable sales occurred at Corpay (CPAY), Aveanna Healthcare (AVAH), Micron Technology (MU), and NLIGHT (LASR). InvestingPro analysis provided fair value assessments for these companies.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AVAH (Aveanna Healthcare Holdings, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent AVAH coverage spans financial news, insider activity and market movers.
In the last 30 days, AVAH insiders filed 19 SEC Form 4 transactions — no purchases and 19 sales ($558.5M). The most active reporter was VIGANO PAUL R with 6 filings.
Higher target could support price.
Analyst upgrade and higher target could sustain price gains.
Massive insider divestiture could signal lack of confidence.
Very large insider sell could negatively impact stock perception.
Large insider sell may pressure the stock and signal reduced confidence from a major shareholder.
AlphAI scores every news story that mentions AVAH with an AI model for sentiment and relevance, and aggregates insider trades from Aveanna Healthcare Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Jim Cramer recommended buying Energy Transfer LP (NYSE:ET), calling it 'terrific.' Stifel analyst Robert Hodges reinstated ET with a Buy rating and $25 price target. Cramer also discussed other stocks, including SentinelOne, Corning, Gemini Space Station, Aveanna Healthcare, Reformation, and HPE, citing various analyst ratings and price targets.
2 min readInspire Medical Systems (NYSE:INSP), Cybin (NASDAQ:HELP), and Aveanna Healthcare (NASDAQ:AVAH) are flagged as overbought with RSI values above 70. INSP reported strong Q2 results and raised FY26 guidance, while AVAH received an Overweight rating and higher price target from Barclays. All three stocks showed significant gains over the past month.
2 min readInsider trading activity for August 25, 2026, included purchases by executives at TTM Technologies (TTMI), Alpha Metallurgical (AMR), Kura Oncology (KURA), TEAM INC (TISI), and Dorchester Minerals (DMLP). Notable sales occurred at Corpay (CPAY), Aveanna Healthcare (AVAH), Micron Technology (MU), and NLIGHT (LASR). InvestingPro analysis provided fair value assessments for these companies.
3 min readInsider trading activity reported for US public companies includes significant purchases and sales. ADAR1 Capital bought 1.03M Tenax Therapeutics (TENX) shares for $1.81M. Kenneth Courtis acquired 15K Alpha Metallurgical (AMR) shares for $3.16M. Rex Geveden bought 5K TTM Technologies (TTMI) shares for $524.5K. Ashley McEvoy, CEO of Insulet (PODD), purchased 1.1K shares for $162.2K. Notable sales include James Wirth selling IHT shares for $1.82B, Alexander Karp selling 492K Palantir (PLTR) shares
3 min readAveanna Healthcare director Paul R. Vigano-linked entities sold $192.6m in stock. Shares were sold at $11.50 each, and the stock has since risen to $13.70. Aveanna reported Q2 2026 revenue of $670.5m, up 13.7% YoY, and raised its full-year outlook. Raymond James and RBC Capital raised their price targets to $15.00 and $16.00, respectively.
2 min readAveanna Healthcare (AVAH) reported that entities linked to 10% owner Robert M. Williams, Jr. sold 16.75M shares of common stock at $11.50 per share on August 20–21, 2026, in an underwritten secondary offering. The total value of the sales was approximately $146.14M. Williams disclaims beneficial ownership except for his pecuniary interest.
1 min readJ.H. Whitney Equity Partners VII, LLC sold 14,746,077 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $11.50 ($169.58M total) across 4 trades over 2026-08-20 to 2026-08-21.
1 min readWILLIAMS ROBERT M JR sold 16,750,002 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $11.50 ($192.63M total) across 6 trades over 2026-08-20 to 2026-08-21.
1 min readAveanna Healthcare (AVAH) reports that entities linked to Paul R. Vigano sold 16,750,002 shares at $11.50 each in underwritten secondary offerings on August 20–21, 2026. Vigano disclaims beneficial ownership except for pecuniary interest. The sales totaled $192.63M.
2 min readVIGANO PAUL R sold 16,750,002 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $11.50 ($192.63M total) across 6 trades over 2026-08-20 to 2026-08-21.
1 min read
